14 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
PD 176252--the first high affinity non-peptide gastrin-releasing peptide (BB2) receptor antagonist.
Cambridge University Forvie Site
Design and synthesis of a targeted set of aromatic amino acid derivatives for identification of new lead compounds
TBA
PD 165929 the first high affinity non-peptide neuromedin-B (NMB) receptor selective antagonist
TBA
Discovery of MK-5046, a Potent, Selective Bombesin Receptor Subtype-3 Agonist for the Treatment of Obesity
TBA
Synthesis and SAR of derivatives based on 2-biarylethylimidazole as bombesin receptor subtype-3 (BRS-3) agonists for the treatment of obesity.
Merck Research Laboratories
Discovery of substituted biphenyl imidazoles as potent, bioavailable bombesin receptor subtype-3 agonists.
Merck Research Laboratories
Discovery of small molecule agonists for the bombesin receptor subtype 3 (BRS-3) based on an omeprazole lead.
Glaxosmithkline
Potent bombesin-like peptides for GRP-receptor targeting of tumors with 99mTc: a preclinical study.
National Center For Scientific Research Demokritos
Identification and optimization of novel partial agonists of neuromedin B receptor using parallel synthesis.
Tularik
Design of selective peptidomimetic agonists for the human orphan receptor BRS-3.
Technische UniversitäT MüNchen
Synthesis, Biological Evaluation, and Molecular Docking of 8-imino-2-oxo-2H,8H-pyrano[2,3-f]chromene Analogs: New Dual AChE Inhibitors as Potential Drugs for the Treatment of Alzheimer's Disease.
Yogi Vemana University